*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
The School of Materials Science and Engineering welcomes Imperial College London Professor Molly Stevens for a seminar on “Bio-inspired Materials for Regenerative Medicine and Sensing.” A reception will precede the talk, at 3:30 in the lobby outside the auditorium.
Abstract
This talk will provide an overview of our recent developments in bio-inspired nanomaterials for tissue regeneration
and sensing. Bio-responsive nanomaterials are of growing importance with potential applications including drug
delivery, diagnostics and tissue engineering. Our recent simple conceptually novel approaches to real-time
monitoring of protease, lipase and kinase enzyme action using modular peptide functionalized NPs will be
presented.
The highly interdisciplinary field of Tissue Engineering (TE) can also benefi t from advances in the design of bio-responsive nanomaterials. TE involves the development of artificial scaffold structures on which new cells are encouraged to grow. The ability to control topography and chemistry at the nanoscale offers exciting possibilities for stimulating growth of new tissue through the development of novel nanostructured scaffolds that mimic the nanostructure of the tissues in the body. Recent developments in this context will be discussed.
About Dr. Stevens
Professor Molly Stevens is Research Director for Biomedical Material Sciences in the Institute of Biomedical Engineering at
Imperial College London. She joined Imperial in 2004 from Postdoctoral training with Professor Robert Langer at MIT. She
graduated from Bath University with a first-class honours degree in Pharmaceutical Sciences and was awarded a PhD in
biophysical investigations from the University of Nottingham (2000).
